On this page
This entry or formulation may be investigational and may not correspond to an FDA-approved product; safety and efficacy may not have been established. Kairo lists it for identification and record-keeping only.
Overview
Product & regulatory status
The cited study does not establish a clinical dementia or cognitive-enhancement treatment.
HGF/c-Met pathway
The study found Dihexa binds HGF and can enhance HGF-dependent activation of c-Met. This is a proposed basis for its experimental synaptic effects. [1]
What the evidence shows
Synapse experiments
Researchers reported effects on dendritic spines and synaptic activity in hippocampal cell systems. These measurements describe experimental neuronal responses rather than improvement in a person’s memory. [1]
Behavioral evidence is preclinical
The same study used a water-maze learning task in animals and interventions targeting HGF signaling. This supports a mechanistic hypothesis but does not establish benefit in Alzheimer’s disease patients. [1]
What remains unknown
Human pharmacology, long-term safety, and clinically meaningful outcomes remain unresolved by this evidence.
Safety
Growth signaling needs careful evaluation
Dihexa’s activity involves HGF/c-Met signaling. The cited laboratory work does not determine the long-term consequences of altering this pathway in people or establish safe combinations with other compounds. [1]
Research compound and delivery context
The HGF study evaluated Dihexa in neuronal experiments and an animal learning model. It did not establish that a topical cream, capsule, or other consumer preparation reproduces the studied exposure. [1]
Understanding product quality
Compounded drugs are not FDA-approved finished products. Poor preparation can cause contamination or incorrect strength. A catalog entry or a research paper is not a quality assessment of your product. [2]
When to seek urgent help
Severe allergic symptoms such as trouble breathing, throat or tongue swelling, or fainting need immediate help. Call 911 or your local emergency number. This is general emergency information, not a complete list of risks for this compound. [3]
A starting point for discussion
This is not a complete list of adverse effects or interactions. Your health history, other medicines, and the exact formulation matter. Missing safety data is not evidence of safety.
Common questions
Are trials of another HGF-targeting drug proof for Dihexa?
No. Similar pathway targets do not establish that two molecules have the same exposure, safety, or clinical effect.
Questions for your clinician
Does the evidence match my condition and this exact product? What risks or interactions matter for me? How would we assess whether it is helping?
Sources
- Dihexa and HGF/c-Met signaling2014 · Original research · PubMed
- Compounding and the FDA: Questions and AnswersFDA · product quality and regulation
- AnaphylaxisMedlinePlus · recognizing an emergency
Educational information, not a recommendation to use a compound. Kairo does not give dosing advice. Review decisions with a licensed healthcare professional.